Repare Therapeutics
RPTX
RPTX was delisted on the 27th of January, 2026.
50 hedge funds and large institutions have $29.1M invested in Repare Therapeutics in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 16 reducing their positions, and 13 closing their positions.
100% more call options, than puts
Call options by funds: $2K | Put options by funds: $1K
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2.63% less ownership
Funds ownership: 72.05% → 69.42% (-2.6%)
7% less funds holding
Funds holding: 54 → 50 (-4)
27% less capital invested
Capital invested by funds: $40.1M → $29.1M (-$11M)
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
38% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$1.13M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$352K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$203K |
| 4 |
AAA
Affinity Asset Advisors
New York
|
+$121K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$48.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$1.06M |
| 2 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
-$678K |
| 3 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$496K |
| 4 |
Morgan Stanley
New York
|
-$233K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$154K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GCP
51
GSA Capital Partners
London,
United Kingdom
| – | -$154K | -117,296 | Closed |
|
52
Goldman Sachs
New York
| – | -$145K | -110,906 | Closed |
|
|
LCM
53
Lynx1 Capital Management
San Juan,
Puerto Rico
| – | -$104K | -79,176 | Closed |
|
|
ETC
54
Exchange Traded Concepts
Oklahoma City,
Oklahoma
| – | -$66.1K | -50,441 | Closed |
|
55
Marshall Wace
London,
United Kingdom
| – | -$61.4K | -46,876 | Closed |
|
|
TRCT
56
Tower Research Capital (TRC)
New York
| – | -$45.1K | -34,423 | Closed |
|
57
Geode Capital Management
Boston,
Massachusetts
| – | -$25.1K | -19,128 | Closed |
|
|
EGM
58
Engineers Gate Manager
New York
| – | -$23.7K | -18,122 | Closed |
|
|
CLOS
59
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| – | -$18.3K | -14,000 | Closed |
|
60
Two Sigma Investments
New York
| – | -$17.6K | -13,467 | Closed |
|
|
AG
61
Algert Global
San Francisco,
California
| – | -$15K | -11,710 | Closed |
|
|
HWM
62
HB Wealth Management
Atlanta,
Georgia
| – | -$15.1K | -11,500 | Closed |
|
63
National Bank of Canada
Montreal,
Quebec, Canada
| – | -$570 | -435 | Closed |
|
RPTX Hedge Fund Activity: Q1 2025 in Review
50 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q1 2025, worth a combined $29.1M — down 27% from $40.1M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of RPTX and 9 opened new positions — a net loss of 4 holders — while 16 trimmed existing stakes and 10 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $1.13M. The largest seller was ARK Investment Management, cutting an estimated $1.06M.
- 50 institutional investors held Repare Therapeutics (RPTX) as of Q1 2025, down from 54 in Q4 2024.
- Funds reported $29.1M of Repare Therapeutics stock for Q1 2025, down 27% quarter-over-quarter.
- 9 funds opened new Repare Therapeutics positions in Q1 2025 and 13 closed out, a net change of -4 holders.
- The largest Repare Therapeutics buyer in Q1 2025 was Citadel Advisors, an estimated $1.13M added.
- The largest Repare Therapeutics seller in Q1 2025 was ARK Investment Management, an estimated $1.06M sold.
Based on aggregated 13F filings for Q1 2025.